全球經皮吸收貼片市場(2023-2033):按配銷通路、應用、最終用戶、貼片類型、黏合劑類型和國家(超過16個國家)的分析和預測
市場調查報告書
商品編碼
1393001

全球經皮吸收貼片市場(2023-2033):按配銷通路、應用、最終用戶、貼片類型、黏合劑類型和國家(超過16個國家)的分析和預測

Global Transdermal Patches Market: Focus on Distribution Channel, Application, End User, Patch Type, Adhesive Type, and Over 16 Countries' Data - Analysis and Forecast, 2023-2033

出版日期: | 出版商: BIS Research | 英文 140 Pages | 商品交期: 1-5個工作天內

價格

隨著全球老年人口的增加以及高血壓、糖尿病和疼痛相關疾病等慢性病盛行率的上升,經皮吸收貼片市場出現了顯著成長。

貼片技術的進步,包括改進的黏合劑,增強的配方和新的輸送機制,也進一步支持市場擴張。

本報告調查了全球經皮吸收貼片市場,並提供了市場背景和概述,分析了市場成長的各種影響因素、研發和專利趨勢、法律制度、使用案例以及市場規模趨勢和預測。各類別、主要國家分析、競爭形勢、主要企業分析等

目錄

第1章 市場

  • 趨勢:當前和未來的影響評估
  • 供應鏈概覽
    • 價值鏈分析
    • 市場地圖
    • 原物料及零件價格預測
  • 研發回顧
    • 專利申請趨勢:依國家和公司分類
  • 監管狀況
  • 利害關係人分析
    • 使用案例
    • 最終用戶和購買標準
  • 全球重大事件影響分析:COVID-19、俄羅斯/烏克蘭、中東危機
  • 市場動態概覽
    • 市場促進因素
    • 市場抑制因素
    • 市場機會

第2章 應用

  • 使用分類
  • 應用概述
  • 全球經皮吸收貼片市場:依應用分類
    • 疼痛管理
    • 荷爾蒙應用
    • 中樞神經系統疾病
    • 心血管疾病
    • 禁止抽煙
    • 其他用途
  • 全球經皮吸收貼片市場:依配銷通路
    • 醫院藥房
    • 零售藥房
    • 線上藥房
  • 全球經皮吸收貼片市場:依最終用戶分類
    • 居家照護
    • 醫院/診所

第3章 產品

  • 產品分類
  • 產品概要
  • 全球經皮吸收貼片市場
    • 市場概況
  • 全球經皮吸收貼片市場:按貼片類型
    • 藥物貼劑
    • 矩陣貼片
    • Reservoir膜貼片
    • 微針貼片
    • 蒸氣貼片
  • 全球經皮吸收貼片市場:依黏合劑類型
    • 丙烯酸黏劑
    • 矽膠黏劑
    • 水凝膠黏劑
    • 其他黏劑

第4章 區域

  • 區域概況
  • 促進因素/抑制因素
  • 北美洲
  • 歐洲
  • 亞太地區
  • 其他地區

第5章 市場:競爭基準化分析/公司簡介

  • 下一個前沿
  • 地理評估
    • Abbvie
    • AdhexPharma
    • Agile Therapeutics
    • Booehringer Ingelheim International GmbH
    • Corium, Inc.
    • Endo Pharmaceuticals Inc.
    • GSK Plc.
    • Himamatsu Pharmaceuticals Co. Ltd.
    • Johnson & Johnson
    • Nitto Denko
    • Novartis AG
    • Optum Rx
    • Prosolus, Inc.
    • Teva Pharmaceuticals
    • Viatris

第6章 調查方法

Product Code: BHM1574SA

“Global Transdermal Patches Market Poised for Robust Growth.”

Introduction to Global Transdermal Patches Market

The transdermal patches market encompasses a dynamic sector within the pharmaceutical industry that focuses on the development, manufacturing, and distribution of patches designed for drug delivery through the skin. These patches offer a non-invasive and convenient alternative to traditional routes of drug administration. Utilizing the skin as a medium for drug absorption, these patches steadily release medication into the bloodstream, ensuring controlled dosing and prolonged therapeutic effects.

The market is witnessing substantial growth owing to the rising prevalence of chronic diseases like hypertension, diabetes, and pain-related conditions, along with an increasing elderly population globally. Advancements in patch technology, including improved adhesives, enhanced drug formulations, and novel delivery mechanisms, are further propelling market expansion.

Market Segmentation:

Segmentation 1: by Application

  • Pain Management
  • Hormonal Application
  • Central Nervous System Disorders
  • Cardiovascular Diseases
  • Smoking Cessation
  • Other Application

Segmentation 2: by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Segmentation 3: by End-User

  • Homecare Settings
  • Hospitals & Clinics

Segmentation 4: by Patch Type

  • Drug-In-Adhesive
  • Matrix Patches
  • Reservoir Membrane Patches
  • Microneedle Patches
  • Vapour Patches

Segmentation 5: by Adhesive Type

  • Acrylic Adhesives
  • Silicone Adhesives
  • Hydrogel Adhesives
  • Other Adhesives

Segmentation 6: by Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest-of-the-World (ROW)

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some of the prominent names in this market are:

  • Abbvie
  • AdhexPharma
  • Agile Therapeutics
  • Booehringer Ingelheim International GmbH
  • Corium, Inc.
  • Endo Pharmaceuticals Inc.
  • GSK Plc.
  • Himamatsu Pharmaceuticals Co. Ltd.
  • Johnson & Johnson
  • Nitto Denko
  • Novartis AG
  • Optum Rx
  • Prosolus, Inc.
  • Teva Pharmaceuticals
  • Viatris

Key Questions to be Answered:

  • How big is the transdermal patches market?
  • What are the major drivers, challenges, and opportunities of the global transdermal patches market?
  • Who are the key players in the transdermal patches market?
  • Which is the fastest growing region in transdermal patches market?
  • Which region has the largest share in the transdermal patches market?

Table of Contents

1 Markets

  • 1.1 Trends : Current and Future Impact Assessment
    • 1.1.1 Sample Text
    • 1.1.2 Trend 1
    • 1.1.3 Trend 2
    • 1.1.4 Trend 3
  • 1.2 Supply chain Overview
    • 1.2.1 Value Chain Analysis
    • 1.2.2 Market Map
    • 1.1.1 Pricing Forecast for Raw Materials and Components
  • 1.3 Research and Development Review
    • 1.3.1 Patent Filing Trend (by Country, Company)
  • 1.4 Regulatory Landscape
  • 1.5 Stakeholder Analysis
    • 1.5.1 Use case
    • 1.5.2 End User and Buying Criteria
  • 1.6 Impact Analysis for Key Global Events- Covid19, Russia/Ukraine or Middle East Crisis
  • 1.7 Market Dynamics Overview
    • 1.7.1 Market Drivers
    • 1.7.2 Market Restraints
    • 1.7.3 Market Opportunities

2 Application

  • 2.1 Application Segmentation
  • 2.2 Application Summary
  • 2.3 Global Transdermal Patches Market (by Application)
    • 2.3.1 Pain Management
    • 2.3.2 Hormonal Application
      • 2.3.2.1 Transdermal Testosterone Therapy
      • 2.3.2.2 Transdermal Oestrogen Therapy
    • 2.3.3 Central Nervous System Disorders
    • 2.3.4 Cardiovascular Diseases
    • 2.3.5 Smoking Cessation
    • 2.3.6 Other Application
  • 2.4 Global Transdermal Patches Market (by Distribution Channel)
    • 2.4.1 Hospital Pharmacies
    • 2.4.2 Retail Pharmacies
    • 2.4.3 Online Pharmacies
  • 2.5 Global Transdermal Patches Market (by End-User)
    • 2.5.1 Homecare Settings
    • 2.5.2 Hospitals & Clinics

3 Products

  • 3.1 Product Segmentation
  • 3.2 Product Summary
  • 3.3 Global Transdermal Patches Market
    • 3.3.1 Market Overview
      • 3.3.1.1 Analyst View
  • 3.4 Global Transdermal Patches Market (by Patch Type)
    • 3.4.1 Drug-In-Adhesive
      • 3.4.1.1 Single Layer Drug in Adhesive Patch
      • 3.4.1.2 Multi-Layer Drug in Adhesive Patch
    • 3.4.2 Matrix Patches
    • 3.4.3 Reservoir Membrane Patches
    • 3.4.4 Microneedle Patches
    • 3.4.5 Vapour Patches
  • 3.5 Global Transdermal Patches Market (By Adhesive Type)
    • 3.5.1 Acrylic Adhesives
    • 3.5.2 Silicone Adhesives
    • 3.5.3 Hydrogel Adhesives
    • 3.5.4 Other Adhesives

4 Regions

  • 4.1 Regional Summary
  • 4.2 Drivers and Restraints
  • 4.3 North America
    • 4.3.1 Regional Overview
    • 4.3.2 Driving Factors for Market Growth
    • 4.3.3 Factors Challenging the Market
    • 4.3.4 Application
    • 4.3.5 Product
    • 4.3.6 U.S.
    • 4.3.7 U.S. Transdermal Patches Market by Application
    • 4.3.8 Canada
    • 4.3.9 Canada Transdermal Patches Market by Application
  • 4.4 Europe
    • 4.4.1 Regional Overview
    • 4.4.2 Driving Factors for Market Growth
    • 4.4.3 Factors Challenging the Market
    • 4.4.4 Application
    • 4.4.5 Product
    • 4.4.6 France
    • 4.4.7 France Transdermal Patches Market by Application
    • 4.4.8 Germany
    • 4.4.9 Germany Transdermal Patches Market by Application
    • 4.4.10 U.K.
    • 4.4.11 U.K. Transdermal Patches Market by Application
    • 4.4.12 Rest of Europe
    • 4.4.13 Rest of Europe Transdermal Patches Market by Application
  • 4.5 Asia Pacific
    • 4.5.1 Regional Overview
    • 4.5.2 Driving Factors for Market Growth
    • 4.5.3 Factors Challenging the Market
    • 4.5.4 Application
    • 4.5.5 Product
    • 4.5.6 China
    • 4.5.7 China Transdermal Patches Market by Application
    • 4.5.8 India
    • 4.5.9 India Transdermal Patches Market by Application
    • 4.5.10 Japan
    • 4.5.11 Japan Transdermal Patches Market by Application
    • 4.5.12 Rest-of-Asia-Pacific
    • 4.5.13 Rest-of-Asia-Pacific Transdermal Patches Market by Application
  • 4.6 Rest-of-the-World
    • 4.6.1 Regional Overview
    • 4.6.2 Driving Factors for Market Growth
    • 4.6.3 Factors Challenging the Market
    • 4.6.4 Application
    • 4.6.5 Product
    • 4.6.6 The Middle East and Africa
    • 4.6.7 The Middle East and Africa Transdermal Patches Market by Application
    • 4.6.8 Latin America
    • 4.6.9 Latin America Transdermal Patches Market by Application

5 Markets - Competitive Benchmarking & Company Profiles

  • 5.1 Next Frontiers…..
  • 5.2 Geographic Assessment
    • 5.2.1 Abbvie
      • 5.2.1.1 Overview
      • 5.2.1.2 Top Products / Product Portfolio
      • 5.2.1.3 Top Competitors
      • 5.2.1.4 Target Customers
      • 5.2.1.5 Key Personnel
      • 5.2.1.6 Analyst View
      • 5.2.1.7 Market Share
    • 5.2.2 AdhexPharma
      • 5.2.2.1 Overview
      • 5.2.2.2 Top Products / Product Portfolio
      • 5.2.2.3 Top Competitors
      • 5.2.2.4 Target Customers
      • 5.2.2.5 Key Personnel
      • 5.2.2.6 Analyst View
      • 5.2.2.7 Market Share
    • 5.2.3 Agile Therapeutics
      • 5.2.3.1 Overview
      • 5.2.3.2 Top Products / Product Portfolio
      • 5.2.3.3 Top Competitors
      • 5.2.3.4 Target Customers
      • 5.2.3.5 Key Personnel
      • 5.2.3.6 Analyst View
      • 5.2.3.7 Market Share
    • 5.2.4 Booehringer Ingelheim International GmbH
      • 5.2.4.1 Overview
      • 5.2.4.2 Top Products / Product Portfolio
      • 5.2.4.3 Top Competitors
      • 5.2.4.4 Target Customers
      • 5.2.4.5 Key Personnel
      • 5.2.4.6 Analyst View
      • 5.2.4.7 Market Share
    • 5.2.5 Corium, Inc.
      • 5.2.5.1 Overview
      • 5.2.5.2 Top Products / Product Portfolio
      • 5.2.5.3 Top Competitors
      • 5.2.5.4 Target Customers
      • 5.2.5.5 Key Personnel
      • 5.2.5.6 Analyst View
      • 5.2.5.7 Market Share
    • 5.2.6 Endo Pharmaceuticals Inc.
      • 5.2.6.1 Overview
      • 5.2.6.2 Top Products / Product Portfolio
      • 5.2.6.3 Top Competitors
      • 5.2.6.4 Target Customers
      • 5.2.6.5 Key Personnel
      • 5.2.6.6 Analyst View
      • 5.2.6.7 Market Share
    • 5.2.7 GSK Plc.
      • 5.2.7.1 Overview
      • 5.2.7.2 Top Products / Product Portfolio
      • 5.2.7.3 Top Competitors
      • 5.2.7.4 Target Customers
      • 5.2.7.5 Key Personnel
      • 5.2.7.6 Analyst View
      • 5.2.7.7 Market Share
    • 5.2.8 Himamatsu Pharmaceuticals Co. Ltd.
      • 5.2.8.1 Overview
      • 5.2.8.2 Top Products / Product Portfolio
      • 5.2.8.3 Top Competitors
      • 5.2.8.4 Target Customers
      • 5.2.8.5 Key Personnel
      • 5.2.8.6 Analyst View
      • 5.2.8.7 Market Share
    • 5.2.9 Johnson & Johnson
      • 5.2.9.1 Overview
      • 5.2.9.2 Top Products / Product Portfolio
      • 5.2.9.3 Top Competitors
      • 5.2.9.4 Target Customers
      • 5.2.9.5 Key Personnel
      • 5.2.9.6 Analyst View
      • 5.2.9.7 Market Share
    • 5.2.10 Nitto Denko
      • 5.2.10.1 Overview
      • 5.2.10.2 Top Products / Product Portfolio
      • 5.2.10.3 Top Competitors
      • 5.2.10.4 Target Customers
      • 5.2.10.5 Key Personnel
      • 5.2.10.6 Analyst View
      • 5.2.10.7 Market Share
    • 5.2.11 Novartis AG
      • 5.2.11.1 Overview
      • 5.2.11.2 Top Products / Product Portfolio
      • 5.2.11.3 Top Competitors
      • 5.2.11.4 Target Customers
      • 5.2.11.5 Key Personnel
      • 5.2.11.6 Analyst View
      • 5.2.11.7 Market Share
    • 5.2.12 Optum Rx
      • 5.2.12.1 Overview
      • 5.2.12.2 Top Products / Product Portfolio
      • 5.2.12.3 Top Competitors
      • 5.2.12.4 Target Customers
      • 5.2.12.5 Key Personnel
      • 5.2.12.6 Analyst View
      • 5.2.12.7 Market Share
    • 5.2.13 Prosolus, Inc.
      • 5.2.13.1 Overview
      • 5.2.13.2 Top Products / Product Portfolio
      • 5.2.13.3 Top Competitors
      • 5.2.13.4 Target Customers
      • 5.2.13.5 Key Personnel
      • 5.2.13.6 Analyst View
      • 5.2.13.7 Market Share
    • 5.2.14 Teva Pharmaceuticals
      • 5.2.14.1 Overview
      • 5.2.14.2 Top Products / Product Portfolio
      • 5.2.14.3 Top Competitors
      • 5.2.14.4 Target Customers
      • 5.2.14.5 Key Personnel
      • 5.2.14.6 Analyst View
      • 5.2.14.7 Market Share
    • 5.2.15 Viatris
      • 5.2.15.1 Overview
      • 5.2.15.2 Top Products / Product Portfolio
      • 5.2.15.3 Top Competitors
      • 5.2.15.4 Target Customers
      • 5.2.15.5 Key Personnel
      • 5.2.15.6 Analyst View
      • 5.2.15.7 Market Share

6 Research Methodology

  • 6.1 Data Sources
    • 6.1.1 Primary Data Sources
    • 6.1.2 Secondary Data Sources
    • 6.1.3 Data Triangulation
  • 6.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Region/country Largest Share of Market
  • Figure 2: Pricing/Cost Analysis by Region, Supply Chain
  • Figure 3: Transdermal Patces Market, by Application, 2023, 2026 and 2033
  • Figure 4: Transdermal Patches Market, 2023, 2026 and 2033
  • Figure 5: Transdermal Patches Market, Patch Type, 2022, 2026 and 2033
  • Figure 6: Transdermal Patches Market, Adhesive Type, 2022, 2026 and 2033
  • Figure 7: Transdermal Patches, Recent Developments
  • Figure 8: Transdermal Patches Market
  • Figure 9: Supply chain and Identifying Risks within the Supply Chain
  • Figure 10: Global Transdermal Patches Market, January 2020-December 2023
  • Figure 11: Global Transdermal Patches Market, January 2020-December 2023
  • Figure 12: Impact Analysis of Market Navigating Factors
  • Figure 13: Global Transdermal Patches Market, 2002 and 2023
  • Figure 14: Global Transdermal Patches Market, 2002 and 2022
  • Figure 15: Global Transdermal Patches Market, 2002 and 2023
  • Figure 16: Global Transdermal Patches Market, 2002 and 2023
  • Figure 17: Global Transdermal Patches Market, 2002 and 2023
  • Figure 18: Global Transdermal Patches Market, 2002 and 2023
  • Figure 19: Global Transdermal Patches Market, 2002 and 2023
  • Figure 20: Global Transdermal Patches Market, 2002 and 2023
  • Figure 21: Global Transdermal Patches Market, 2002 and 2023
  • Figure 22: U.S. Transdermal Patches Market, By Appliation Type ($ Million), 2022-2033
  • Figure 23: U.S. Transdermal Patches Market, By End User ($ Million), 2022-2033
  • Figure 24: Canada Transdermal Patches Market, By Application Type ($ Million), 2022-2033
  • Figure 25: Canada Transdermal Patches Market, By End User ($ Million), 2022-2033
  • Figure 26: France Transdermal Patches Market, By Application Type ($ Million), 2022-2033
  • Figure 27: France Transdermal Patches Market, By End User ($ Million), 2022-2033
  • Figure 28: Germany Transdermal Patches Market, By Application Type ($ Million), 2022-2033
  • Figure 29: Germany Transdermal Patches Market, By End User ($ Million), 2022-2033
  • Figure 30: U.K. Transdermal Patches Market, By Distribution Channel ($ Million), 2022-2033
  • Figure 31: U.K. Transdermal Patches Market, By End User ($ Million), 2022-2033
  • Figure 32: Rest of Europe Transdermal Patches Market, By Application Type ($ Million), 2022-2033
  • Figure 33: Rest of Europe Transdermal Patches Market, By End User($ Million), 2022-2033
  • Figure 34: China Transdermal Patches Market, By Application Type ($ Million), 2022-2033
  • Figure 35: China Transdermal Patches Market, By End User ($ Million), 2022-2033
  • Figure 36: India Transdermal Patches Market, By Application Type Million), 2022-2033
  • Figure 37: India Transdermal Patches Market, By End User ($ Million), 2022-2033
  • Figure 38: Japan Transdermal Patches Market, By Application Type ($ Million), 2022-2033
  • Figure 39: Japan Transdermal Patches Market, By End User ($ Million), 2022-2033
  • Figure 40: Rest-of-Asia-Pacific Transdermal Patches Market, By Application Type ($ Million), 2022-2033
  • Figure 41: Rest-of-Asia-Pacific Transdermal Patches Market, By End User ($ Million), 2022-2033
  • Figure 42: The Middle East and Africa Transdermal Patches Market, By Application Type ($ Million), 2022-2033
  • Figure 43: The Middle East and Africa Transdermal Patches Market, By End User ($ Million), 2022-2033
  • Figure 44: Latin America Transdermal Patches Market, By Application Type ($ Million), 2022-2033
  • Figure 45: Latin America Transdermal Patches Market, By End User ($ Million), 2022-2033
  • Figure 46: Strategic Initiatives, 2020 - 2023
  • Figure 47: Share of Strategic Initiatives
  • Figure 48: Data Triangulation
  • Figure 49: Top-Down and Bottom-Up Approach
  • Figure 50: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Transdermal Patches Market, by Country
  • Table 3: Global Transdermal Patches Market, by Patch Type, $Million, 2023-2033
  • Table 4: Global Transdermal Patches Market, by Adhesive Type, $Million, 2022-2033
  • Table 5: Global Transdermal Patches Market, By Region, ($ Million), 2023-2033
  • Table 6: North America Transdermal Patches Market, By Application ($ Million), 2022-2033
  • Table 7: North America Transdermal Patches Market, By End User ($ Million), 2022-2033
  • Table 8: North America Transdermal Patches Market, By Patch Type ($ Million), 2022-2033
  • Table 9: North America Transdermal Patches Market, By Application ($ Million), 2022-2033
  • Table 10: North America Transdermal Patches Market, By End User ($ Million), 2022-2033
  • Table 1: North America Transdermal Patches Market, By Application ($ Million), 2022-2033
  • Table 2: North America Transdermal Patches Market, By End User ($ Million), 2022-2033
  • Table 3: Europe Transdermal Patches Market, By Application ($ Million), 2022-2033
  • Table 4: Europe Transdermal Patches Market, By End User ($ Million), 2022-2033
  • Table 5: Europe Transdermal Patches Market, By Patch Type ($ Million), 2022-2033
  • Table 6: North America Transdermal Patches Market, By Application ($ Million), 2022-2033
  • Table 7: North America Transdermal Patches Market, By End User ($ Million), 2022-2033
  • Table 8: France Transdermal Patches Market, By Product Type ($ Million), 2022-2033
  • Table 9: Germany Transdermal Patches Market, By Application ($ Million), 2022-2033
  • Table 10: Geermany Transdermal Patches Market, By End User ($ Million), 2022-2033
  • Table 11: U.K. Transdermal Patches Market, By Application ($ Million), 2022-2033
  • Table 12: U.K. Transdermal Patches Market, By End User ($ Million), 2022-2033
  • Table 13: Rest of Europe Transdermal Patches Market, By Application ($ Million), 2022-2033
  • Table 14: Rest of Europe Transdermal Patches Market, By End User ($ Million), 2022-2033
  • Table 15: Asia Pacific Transdermal Patches Market, By Application ($ Million), 2022-2033
  • Table 16: Asia Pacific Transdermal Patches Market, By Distribution Channel ($ Million), 2022-2033
  • Table 17: Asia Pacific Transdermal Patches Market, By End User ($ Million), 2022-2033
  • Table 18: Asia Pacific Transdermal Patches Market, By Patch Type ($ Million), 2022-2033
  • Table 19: Asia Pacific Transdermal Patches Market, By Adhesive Type ($ Million), 2022-2033
  • Table 20: China Transdermal Patches Market, By Application Type ($ Million), 2022-2033
  • Table 21: China Transdermal Patches Market, By End User ($ Million), 2022-2033
  • Table 22: India Transdermal Patches Market, By Application Type ($ Million), 2022-2033
  • Table 23: India Transdermal Patches Market, By End User ($ Million), 2022-2033
  • Table 24: Japan Transdermal Patches Market, By Application Type ($ Million), 2022-2033
  • Table 25: Japan Transdermal Patches Market, By End User ($ Million), 2022-2033
  • Table 26: Rest-of-Asia-Pacific Transdermal Patches Market, By Application Type ($ Million), 2022-2033
  • Table 27: Rest-of-Asia-Pacific Transdermal Patches Market, By End User ($ Million), 2022-2033
  • Table 28: Rest-of-the-World Transdermal Patches Market, By Application ($ Million), 2022-2033
  • Table 29: Rest-of-the-World Transdermal Patches Market, By End User ($ Million), 2022-2033
  • Table 30: Rest-of-the-World Transdermal Patches Market, By Patch Type ($ Million), 2022-2033
  • Table 31: The Middle East and Africa Transdermal Patches Market, By Platform (In $ Million), 2022-2033
  • Table 32: The Middle East and Africa Transdermal Patches Market, By Platform ($ Million), 2022-2033
  • Table 33: Latin America Transdermal Patches Market, By Application Type ($ Million), 2022-2033
  • Table 34: Latin America Transdermal Patches Market, By End User ($ Million), 2022-2033
  • Table 35: Market Share